We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WHLR
4126
Wheeler Real Estate Investment Trust
WHLR
$549K
0
TCVA
4127
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$328K ﹤0.01%
+33,198
New +$337K
VOSO
4128
DELISTED
Virtuoso Acquisition Corp. Class A Common Stock
VOSO
$327K ﹤0.01%
+33,045
New +$323K
SWKH
4129
DELISTED
SWK Holdings
SWKH
$326K ﹤0.01%
23,464
-25,948
-53% -$339K
SY
4130
So-Young International
SY
$185M
$326K ﹤0.01%
33,998
PRAH
4131
DELISTED
PRA Health Sciences, Inc.
PRAH
$325K ﹤0.01%
1,969
-802,718
-100% -$134M
IAG icon
4132
IAMGOLD
IAG
$8.2B
$323K ﹤0.01%
109,758
SMRT icon
4133
SmartRent
SMRT
$195M
$323K ﹤0.01%
26,288
+15,554
+145% +$168K
NTRP icon
4134
NextTrip
NTRP
$24.2M
$323K ﹤0.01%
4,152
+1,766
+74% +$131K
CFIV
4135
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$321K ﹤0.01%
33,157
+6,446
+24% +$62.9K
CODA icon
4136
Coda Octopus Group
CODA
$114M
$320K ﹤0.01%
36,813
+3,007
+9% +$25.6K
EDRY icon
4137
EuroDry
EDRY
$76.6M
$320K ﹤0.01%
13,176
-25,747
-66% -$464K
AUTL
4138
Autolus Therapeutics
AUTL
$397M
$319K ﹤0.01%
48,162
+32,379
+205% +$201K
HLMN icon
4139
Hillman Solutions
HLMN
$1.54B
$319K ﹤0.01%
+25,759
New +$287K
DCRC
4140
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
$318K ﹤0.01%
+30,710
New +$320K
BROG
4141
DELISTED
Brooge Energy
BROG
$317K ﹤0.01%
37,918
TRIT
4142
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
$316K ﹤0.01%
45,458
LAC
4143
DELISTED
Lithium Americas Corp. Common Shares
LAC
$316K ﹤0.01%
21,286
+3,459
+19% +$49.4K
CLS icon
4144
Celestica
CLS
$38.1B
$314K ﹤0.01%
39,947
+10,004
+33% +$83.5K
LUB
4145
DELISTED
Luby's Inc.
LUB
$314K ﹤0.01%
81,922
TBIO
4146
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$313K ﹤0.01%
+792
New +$280K
SYPR icon
4147
Sypris Solutions
SYPR
$42.8M
$312K ﹤0.01%
83,875
+6,233
+8% +$20.7K
VET icon
4148
Vermilion Energy
VET
$1.82B
$312K ﹤0.01%
35,644
UMC icon
4149
United Microelectronic
UMC
$47.7B
$310K ﹤0.01%
32,874
-2,189
-6% -$20.5K
ADAP
4150
DELISTED
Adaptimmune Therapeutics
ADAP
$309K ﹤0.01%
72,769

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.